Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する概念動画

Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

1.2K
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
1.2K
Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

1.1K
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
1.1K
Inflammatory Bowel Disease V: Surgical Management01:21

Inflammatory Bowel Disease V: Surgical Management

652
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
652
Inflammatory Bowel Disease IV: Pharmacological Management01:29

Inflammatory Bowel Disease IV: Pharmacological Management

743
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
743
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

860
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
860
Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

1.8K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.8K

こちらも読む

関連記事

共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

並び替え
Same author

Letter: Does the Association Between Mild Endoscopic Activity and Adverse Outcomes Justify Treatment Escalation in Older Adults With Inflammatory Bowel Disease? Authors' Reply.

Alimentary pharmacology & therapeutics·2026
Same author

The impact of normalization of histology on disease course in microscopic colitis: a retrospective cohort study.

Inflammatory bowel diseases·2026
Same author

Impact of advanced therapy initiation on antibiotic dependence in chronic pouchitis.

Inflammatory bowel diseases·2026
Same author

Endoscopic recurrence of Crohn's disease following laparoscopic versus robotic ileocolic resection.

Techniques in coloproctology·2026
Same author

Outcomes of transcatheter vs. surgical aortic valve replacement in bicuspid aortic valve stenosis: A systematic review and meta-analysis.

Indian journal of thoracic and cardiovascular surgery·2026
Same author

Microbiome-Directed Therapy for Fatigue in Quiescent Inflammatory Bowel Disease: A Randomized Placebo-Controlled Trial of Multistrain Probiotic Supplementation.

The American journal of gastroenterology·2026
Same journal

Calendar of Courses, Symposiums and Conferences.

The American journal of gastroenterology·2026
Same journal

Molecular Nonendoscopic Tests for the Early Detection of Esophageal Squamous Carcinoma and High-Grade Dysplasia: Promising Progress.

The American journal of gastroenterology·2026
Same journal

ACG Clinical Guideline: Colonic Diverticulitis.

The American journal of gastroenterology·2026
Same journal

Continuing Medical Education Questions: July 2026.

The American journal of gastroenterology·2026
Same journal

Continuing Medical Education Questions: July 2026.

The American journal of gastroenterology·2026
Same journal

2026 CME Information.

The American journal of gastroenterology·2026
関連記事をすべて見る

関連する実験動画

Updated: Feb 14, 2026

Dynamic Adhesion Assay for the Functional Analysis of Anti-adhesion Therapies in Inflammatory Bowel Disease
08:27

Dynamic Adhesion Assay for the Functional Analysis of Anti-adhesion Therapies in Inflammatory Bowel Disease

Published on: September 20, 2018

8.1K

認知機能と活発な炎症性腸疾患の双方向的な関係

Bharati Kochar1,2,3, Adam S Faye4, Elizabeth Araka1

  • 1Division of Gastroenterology, Massachusetts General Hospital, Boston, MA.

The American journal of gastroenterology
|February 13, 2026
PubMed
まとめ
この要約は機械生成です。

認知機能障害は,炎症性腸疾患 (IBD) の高齢者に多く見られます. アクティブIBDは,認知機能の悪化,特に遅れたリコールに関連しており,この集団において効果的なIBD治療の必要性を強調しています.

キーワード:
クローン病は,クローン病である.老化,老化は,老化しています.認知症 認知症ゲリアトリクス ゲリアトリクス潰瘍性大腸炎について

さらに関連する動画

Characterizing the Relationship Between Eye Movement Parameters and Cognitive Functions in Non-demented Parkinson's Disease Patients with Eye Tracking
07:26

Characterizing the Relationship Between Eye Movement Parameters and Cognitive Functions in Non-demented Parkinson's Disease Patients with Eye Tracking

Published on: September 26, 2019

8.4K
DNBS/TNBS Colitis Models: Providing Insights Into Inflammatory Bowel Disease and Effects of Dietary Fat
09:04

DNBS/TNBS Colitis Models: Providing Insights Into Inflammatory Bowel Disease and Effects of Dietary Fat

Published on: February 27, 2014

49.0K

関連する実験動画

Last Updated: Feb 14, 2026

Dynamic Adhesion Assay for the Functional Analysis of Anti-adhesion Therapies in Inflammatory Bowel Disease
08:27

Dynamic Adhesion Assay for the Functional Analysis of Anti-adhesion Therapies in Inflammatory Bowel Disease

Published on: September 20, 2018

8.1K
Characterizing the Relationship Between Eye Movement Parameters and Cognitive Functions in Non-demented Parkinson's Disease Patients with Eye Tracking
07:26

Characterizing the Relationship Between Eye Movement Parameters and Cognitive Functions in Non-demented Parkinson's Disease Patients with Eye Tracking

Published on: September 26, 2019

8.4K
DNBS/TNBS Colitis Models: Providing Insights Into Inflammatory Bowel Disease and Effects of Dietary Fat
09:04

DNBS/TNBS Colitis Models: Providing Insights Into Inflammatory Bowel Disease and Effects of Dietary Fat

Published on: February 27, 2014

49.0K

科学分野:

  • ゲリアトリック・メディシン (老年医学)
  • 神経科学は神経科学である.
  • 胃腸内科 胃腸内科

背景:

  • 認知障害は重要な高齢者症候群であり,認知症の前兆である.
  • 炎症性腸疾患 (IBD) は,高齢者の増加に起因しています.
  • IBDの高齢者の認知機能を理解することは,早期発見と介入に不可欠です.

研究 の 目的:

  • IBDと診断された60歳以上の成人の認知機能を記述する.
  • IBDの活動と認知機能の関連性を調査する.
  • IBD患者の認知機能低下に対する早期スクリーニングの潜在的ツールを特定する.

主な方法:

  • 60歳以上のIBD患者356人のコホートは,米国の6つのセンターから募集されました.
  • 人口統計,IBD歴,疾患活動指数,モントリオール認知評価 (MoCA) が収集されました.
  • 多変数ロジスティック回帰モデルは,1年以上にわたる認知機能の変化とIBDの活動を分析しました.

主要な成果:

  • 開始時点で,42%の被験者が認知障害のスクリーニングで陽性であったが,遅延記憶と視覚空間機能の欠陥が最も一般的であった.
  • 1年以内に,31%がMoCAスコアを改善し,19%が低下した.
  • 発症時の症状のあるIBDは,フォローアップ時の認知テストの悪化を有意に予測した (aOR: 3.01).

結論:

  • 高齢者のIBDの効果的な管理は,認知機能低下を軽減するために不可欠です.
  • MoCAのサブドメインである遅延リコールにおける欠陥は,活発なIBDと有意に関連しています.
  • 遅延した記憶は,高齢のIBD患者における認知障害の重要なスクリーニングツールとして役立つかもしれません.